Sophia Genetics SA (NAS:SOPH)
$ 3.65 -0.34 (-8.52%) Market Cap: 242.50 Mil Enterprise Value: 200.98 Mil PE Ratio: 0 PB Ratio: 2.13 GF Score: 56/100

Full Year 2022 Sophia Genetics SA Earnings Call Transcript

Mar 07, 2023 / 01:00PM GMT
Release Date Price: $2.53 (-1.94%)
Operator

Good morning, and welcome to SOPHiA GENETICS' Fourth Quarter Fiscal 2022 Earnings Call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Katherine Bailon, Head of Investor Relations at SOPHiA GENETICS. Please go ahead.

Katherine Bailon
SOPHiA GENETICS SA - VP of IR

Good morning, and thank you for joining us on SOPHiA GENETICS Q4 Fiscal 2022 Earnings Call. My name is Katherine Bailon, and I am Head of Investor Relations at SOPHiA GENETICS. Joining me today are Dr. Jurgi Camblong, our Co-Founder and Chief Executive Officer; and Ross Muken, our Chief Financial Officer.

Before we get started, I'd like to remind you that the management team will make statements during this call that are forward-looking within the meaning of U.S. federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these risks and uncertainties appear in the section

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot